²é¿´: 1208  |  »Ø¸´: 2

ÓÐÈË¿´µ½ÎҵĶú»

Ìú³æ (³õÈëÎÄ̳)

[½»Á÷] Ìì½òÒ½¿Æ´óѧ»ù´¡Ò½Ñ§ÔºÕÔÀö½ÌÊÚ¿ÎÌâ×齲ʦ¡¢²©ºó¼°¿ÆÑÐÖúÀíÕÐÆ¸

¾ßÌ幤×÷µØµã:
Ìì½òÊÐºÍÆ½ÇøÆøÏǫ́·22ºÅÌì½òÒ½¿Æ´óѧ»ù´¡Ò½Ñ§Ôº
н½ð:
ÔÂн°ËǧÖÁÒ»Íò
ѧÀúºÍÑо¿·½Ïò:
ÉúÎҽѧ¡¢Ò©Ñ§µÈ
ÕÐÆ¸¸Úλ:
½²Ê¦/²©ºó/¿ÆÑÐÖúÀí
¹«Ë¾Ãû³Æ:
Ìì½òÒ½¿Æ´óѧ
ÁªÏµ·½Ê½:
shzhaoli@tmu.edu.cn

¿ÎÌâ×é½éÉÜ
       ÕÔÀö½ÌÊÚΪÌì½òÒ½¿Æ´óѧ»ù´¡Ò½Ñ§ÔºÉúÎﻯѧÓë·Ö×ÓÉúÎïѧϵ½ÌÊÚ£¬Ìì½òÊÐÌØÆ¸½ÌÊÚ£¬²©Ê¿Éúµ¼Ê¦¡£
       ¿ÎÌâ×鳤ÆÚÖÂÁ¦ÓÚÁ˽âÏÂÇðÄÔ-´¹Ì壬¼××´ÏÙ£¬ÈéÏÙµÈÉñ¾­ÄÚ·ÖÃÚ»·Â·ÖÐµÄÆ÷¹Ù·¢Óý£¬²¢ÒÔ´ËÍÆ½ø¶ÔÏà¹Ø¼²²¡ºÍ°©Ö¢·¢Éú»úÖÆµÄÀí½â¡£ÀûÓÃת»ùÒòСÊó¹¹½¨¸÷ÖÖÌù½üÁÙ´²ÉúÀí¼²²¡ºÍ°©Ö¢µÄ¶¯Îï¼²²¡Ä£ÐÍ£»½Òʾ²¢×·×ÙÆ÷¹Ù·¢ÓýºÍÖ×Áö·¢ÉúµÄ¹Ø¼üÆðʼϸ°ûµÄ£»ÒÔǰÆÚ·Ö×Ó»úÖÆÍÚ¾òºÍÄÉÃ×°ÐÏòÒ©ÎïµÄ¿ª·¢ÓëµÝËÍΪ»ù´¡£¬Îª°©Ö¢ÖÎÁÆÌرðÊÇÄÑÖÎÐÔ¡¢×ªÒÆÐÔ°©Ö¢µÄÖÎÁÆÌṩ°ÐÏòÐÔÓëÓÐЧÐԸߡ¢¸±×÷ÓÃСµÄÖÎÁƲßÂÔ¡£
¿ÎÌâ×é³É¹û£º
       ·¢±íÔÚMolecular Cell¡¢Developmental Cell¡¢Nature Communications¡¢Development¡¢Oncogene¡¢Journal of Bone and Mineral Research¡¢ACS NanoµÈÔÓÖ¾20ÓàÆª¡£
1. Zhang Z, Wu Y, Fu J, Yu X, Su Y, Jia S, Cheng H, Shen Y, He X, Ren K, Zheng X, Guan H, Rao F, Zhao L. (2024) Proteostatic reactivation of the developmental transcription factor TBX3 drives BRAF/MAPK-mediated tumorigenesis.Nat Commun. 15(1):4108.
2. Zhang P, Guan L, Sun W, Zhang Y, Du Y, Yuan S, Cao X, Yu Z, Jia Q, Zheng X, Meng Z, Li X, Zhao L.(2024) Targeting miR-31 represses tumourigenesis and dedifferentiation of BRAFV600E-associated thyroid carcinoma. Clin Transl Med. 14(5):e1694.
3. Su Y, Luo Y, Zhang P, Lin H, Pu W, Zhang H, Wang H, Hao Y, Xiao Y, Zhang X, Wei X, Nie S,Zhang K, Fu Q, Chen H, Huang N, Ren Y, Wu M, Chow BKC, Chen X, Jin W, Wang F, Zhao L*, Rao F*. (2023) Glucose-induced CRL4COP1-p53 axis amplifies glycometabolism to drive tumorigenesis. Mol Cell. 83(13):2316-2331.e7.
4¡¢Zhang P, Guan H, Yuan S, Cheng H, Zhang Z, Zheng J, Yu Y, Meng Z, Zheng X, Zhao L*. (2022) Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors. Nat Commun. 13(1):1588
5¡¢Yuan S, Zhang P, Wen L, Jia S, Wu Y, Zhang Z, Guan L, Yu Z, Zhao L*. (2021) miR-22 promotes stem cell traits via activating Wnt/¦Â-catenin signaling in cutaneous squamous cell carcinoma. Oncogene. 40(39):5799-5813
6¡¢Bi X, Lou P, Song Y, Sheng X, Liu R, Deng M, Yang X, Li G, Zhang B, Xue L, Liu Z, Plikus M, Ren F, Gao S, Yuan S, Zhang H, Jiao B, Zhao L*, Yu Z* (2021) Msi1 promotes breast cancer metastasis by regulating invadopodia-mediated extracellular matrix degradation via the Timp3-Mmp9 pathway. Oncogene. 40(29):4832-4845
ÕÐÆ¸¸Úλ¼°ÒªÇó£º
1. ¿ÆÑÐÖúÀí1Ãû£ºÄêÁä¡Ü30ÖÜË꣬¾ßÓÐ˶ʿÑо¿Éú¼°ÒÔÉÏѧÀúºÍѧ룬ÉúÎҽѧ¡¢Ò©Ñ§µÈÏà¹Ø×¨Òµ·½Ïò¡£ÈȰ®¿ÆÑУ¬³Ô¿àÄÍÀÍ£¬¾ßÓÐÍŶÓЭ×÷¾«Éñ£¡ÊìÁ·ÕÆÎÕϸ°ûÅàÑø¡¢»ù±¾µÄÉú»¯ºÍ·Ö×ÓÉúÎïѧʵÑé¼¼ÄÜ£¬µÚ1×÷Õß·¢±íÓÐSCIÂÛÎÄÕßÓÅÏÈ¡£
2. ½²Ê¦1Ãû£¬²©Ê¿ºó1Ãû£ºÄêÁä¡Ü35ÖÜË꣬¾ßÓв©Ê¿Ñо¿ÉúѧÀúºÍѧ룬Ö×Áö¡¢ÌÇÖ¬´úлºÍ±í¹ÛÒÅ´«µÈÏà¹Ø×¨Òµ·½Ïò¡£ÈȰ®¿ÆÑУ¬³Ô¿àÄÍÀÍ£¬¾ßÓÐÍŶÓЭ×÷¾«Éñ£¡È¡µÃ½ÏºÃµÄÑо¿³É¹û£¨ÒÔµÚ1×÷Õß·¢±íQ1ÇøSCIÂÛÎÄÕßÓÅÏÈ£©²¢ÇҾ߱¸Á¼ºÃµÄ·¢Õ¹Ç±Á¦£»¾ßÓжÀÁ¢µÄ¿ÎÌâÉè¼ÆÄÜÁ¦ºÍÔúʵµÄʵÑé²Ù×÷ÄÜÁ¦£¬Äܹ»ÔÚPIµÄÖ¸µ¼Ï¶ÀÁ¢Õ¹¿ªÑо¿¹¤×÷£¬²¢²ÎÓëÑо¿ÉúµÄÖ¸µ¼¹¤×÷¡£

н³ê´ýÓö£º
1. ´ýÓö²ÎÕÕÌì½òÒ½¿Æ´óѧÏà¹ØÈËÊÂÕþ²ß²¢´ÓÓÅ¡£
2. Ìṩ¿ÆÑÐÖ¸µ¼£¬²Î¼Ó¹úÄÚÍâѧÊõ»áÒéµÄ»ú»á£¬È«Á¦Ö§³ÖÉêÇë¸÷ÖÖ»ù½ðºÍÈ˲ÅÏîÄ¿¡£
3. ¿ÆÑÐÖúÀíÒµÎñÊìÁ·Õß¿ÉÍÆ¼ö¼ÌÐø¶Á²©

»¶Ó­Ö¾È¤ÏàͶ¡¢ÈȰ®¿ÆÑС¢Çڷܿ̿àµÄ¿ÆÑÐÖúÀí¡¢²©Ê¿ºóºÍ½²Ê¦Ó¦Æ¸Õß¼ÓÈë¿ÎÌâ×飡
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

½ðÔÀÔÀÔÀÒ©

гæ (³õÈëÎÄ̳)

½ñÄê6Ô²űÏÒµ¿ÉÒÔÂð
2Â¥2025-02-26 10:37:19
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ÓÐÈË¿´µ½ÎҵĶú»

Ìú³æ (³õÈëÎÄ̳)

ÒýÓûØÌû:
2Â¥: Originally posted by ½ðÔÀÔÀÔÀÒ© at 2025-02-26 10:37:19
½ñÄê6Ô²űÏÒµ¿ÉÒÔÂð

µ±È»¿ÉÒÔѽ
3Â¥2025-04-16 17:19:12
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ ÓÐÈË¿´µ½ÎҵĶú» µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 081700»¯¹¤Ñ§Ë¶µ÷¼Á +3 ¡¾1¡¿ 2026-03-16 3/150 2026-03-19 23:40 by edmund7
[¿¼ÑÐ] 296Çóµ÷¼Á +3 www_q 2026-03-18 6/300 2026-03-19 22:28 by zhq0425
[¿¼ÑÐ] ÄÜÔ´²ÄÁÏ»¯Ñ§¿ÎÌâ×éÕÐÊÕ˶ʿÑо¿Éú8-10Ãû +4 ÍÑÓ±¶ø³ö 2026-03-16 12/600 2026-03-19 16:17 by ÍÑÓ±¶ø³ö
[¿¼ÑÐ] ÕÐÊÕµ÷¼Á˶ʿ +4 lidianxing 2026-03-19 10/500 2026-03-19 16:05 by Óà÷ëÓà
[¿¼ÑÐ] 317Çóµ÷¼Á +3 Éê×ÓÉêÉê 2026-03-19 6/300 2026-03-19 14:16 by Éê×ÓÉêÉê
[¿¼ÑÐ] Ò»Ö¾Ô¸Ìì´ó²ÄÁÏÓ뻯¹¤£¨085600£©×Ü·Ö338 +5 ²Ì´óÃÀÅ® 2026-03-13 5/250 2026-03-19 10:44 by ÊÇСÁõѽ¡«
[¿¼ÑÐ] 332Çóµ÷¼Á +3 ydfyh 2026-03-17 3/150 2026-03-19 10:14 by ¹¦·ò·è¿ñ
[¿¼ÑÐ] 311Çóµ÷¼Á +4 ¶¬Ê®Èý 2026-03-18 4/200 2026-03-18 21:47 by ¾¡Ë´Ò¢1
[¿¼ÑÐ] 070300»¯Ñ§319Çóµ÷¼Á +6 ½õÀð0909 2026-03-17 6/300 2026-03-18 13:22 by Iveryant
[¿¼²©] »·¾³ÁìÓòÈ«¹úÖØµãʵÑéÊÒÕÐÊÕ²©Ê¿1-2Ãû +3 QGZDSYS 2026-03-13 5/250 2026-03-18 11:13 by QGZDSYS
[¿¼ÑÐ] 293Çóµ÷¼Á +11 zjlµÄºÅ 2026-03-16 16/800 2026-03-18 08:10 by zhukairuo
[¿¼ÑÐ] Ò»Ö¾Ô¸ËÕÖÝ´óѧ²ÄÁϹ¤³Ì£¨085601£©×¨Ë¶ÓпÆÑо­ÀúÈýÏî¹ú½±Á½¸öʵÓÃÐÍרÀûÒ»ÏîÊ¡¼¶Á¢Ïî +6 ´ó»ðɽС»ðɽ 2026-03-16 8/400 2026-03-17 15:05 by ÎÞи¿É»÷111
[¿¼ÑÐ] 302Çóµ÷¼Á +4 С¼Öͬѧ123 2026-03-15 8/400 2026-03-17 10:33 by С¼Öͬѧ123
[¿¼ÑÐ] ¶«ÄÏ´óѧ364Çóµ÷¼Á +5 JasonYuiui 2026-03-15 5/250 2026-03-16 21:28 by ľ¹Ï¸à
[¿¼ÑÐ] 0854¿ØÖƹ¤³Ì 359Çóµ÷¼Á ¿É¿çרҵ +3 626776879 2026-03-14 9/450 2026-03-16 17:42 by 626776879
[¿¼ÑÐ] 304Çóµ÷¼Á +3 ÂüÊâ2266 2026-03-14 3/150 2026-03-16 16:39 by houyaoxu
[¿¼ÑÐ] 326Çóµ÷¼Á +3 mlpqaz03 2026-03-15 3/150 2026-03-16 07:33 by Iveryant
[¿¼ÑÐ] 327Çóµ÷¼Á +6 ʰ¹âÈÎȾ 2026-03-15 11/550 2026-03-15 22:47 by ʰ¹âÈÎȾ
[¿¼ÑÐ] ÇóÀÏʦÊÕÁôµ÷¼Á +4 jiang½ª66 2026-03-14 5/250 2026-03-15 20:11 by Winj1e
[¿¼ÑÐ] ²ÄÁÏÓ뻯¹¤ 323 Ó¢Ò»+Êý¶þ+Îﻯ£¬Ò»Ö¾Ô¸£º¹þ¹¤´ó ±¾È˱¾¿ÆË«Ò»Á÷ +4 ×ÔÓɵÄ_·ÉÏè 2026-03-13 5/250 2026-03-14 19:39 by hmn_wj
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û